Indication
Calcitonin is indicated for: Prevention of acute bone loss due to sudden immobilisation such as in patients with recent osteoporotic fractures Paget's disease Hypercalcaemia of malignancy
Loading your page…
Loading your page…
Hypercalcemia;Osteitis Deformans;Bone Resorption
Marketing Authorisation Holder: Unigene UK Ltd.
EMA Authorisation: 11/01/1999
INN: recombinant salmon calcitonin
AI Drug & Interaction Analysis
Free account required
Ask Osler about Forcaltonin: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.